Postischemic Administration of IL-1α Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke.

Authors :: Liberale L
Bonetti NR
Puspitasari YM
Schwarz L
Akhmedov A
Montecucco F
Ruschitzka F
Beer JH
Lüscher TF
Simard J
Libby P
Camici GG
Source :: Circulation [Circulation] 2020 Jul 14; Vol. 142 (2), pp. 187-189. Date of Electronic Publication: 2020 Jul 13.
Publication Year :: 2020

Subjects :: Animals
Brain Infarction etiology
Brain Infarction metabolism
Brain Infarction pathology
Disease Management
Disease Models, Animal
Disease Susceptibility
Endothelins metabolism
Ischemic Stroke diagnosis
Ischemic Stroke therapy
Male
Mice
Antibodies, Monoclonal pharmacology
Antibodies, Neutralizing pharmacology
Interleukin-1alpha antagonists & inhibitors
Ischemic Stroke etiology
Ischemic Stroke metabolism

Full Text Access

Tools